Non-vitamin K antagonist oral anticoagulants reduce all-cause mortality, major bleeding and intracerebral hemorrhage but higher risk of gastro-intestinal bleeding according to...
Rivaroxaban significantly lowered the combined risk of stroke, cardiovascular death and heart attack in patient with chronic coronary or peripheral artery disease by 24%
Im...
